Abstract
As the molecular design requirements for the preparation of nasally mucoadhesive polymers that are capable of combining the controlled and site-specific delivery of macromolecular therapeutic agents with penetration-enhancing properties are now reasonably well understood, the nasal delivery of insulin is fast becoming a technological reality.
| Original language | English |
|---|---|
| Pages (from-to) | 1241-1243 |
| Number of pages | 3 |
| Journal | Therapeutic Delivery |
| Volume | 3 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2012 |
